Effect of the STRIDE fall injury prevention intervention on falls, fall injuries, and health-related quality of life.

care management falls health-related quality of life older persons pragmatic trials

Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
11 2022
Historique:
revised: 29 05 2022
received: 14 05 2022
accepted: 05 06 2022
pubmed: 7 8 2022
medline: 15 11 2022
entrez: 6 8 2022
Statut: ppublish

Résumé

Falls are common in older adults and can lead to severe injuries. The Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) trial cluster-randomized 86 primary care practices across 10 health systems to a multifactorial intervention to prevent fall injuries, delivered by registered nurses trained as falls care managers, or enhanced usual care. STRIDE enrolled 5451 community-dwelling older adults age ≥70 at increased fall injury risk. We assessed fall-related outcomes via telephone interviews of participants (or proxies) every 4 months. At baseline, 12 and 24 months, we assessed health-related quality of life (HRQOL) using the EQ-5D-5L and EQ-VAS. We used Poisson models to assess intervention effects on falls, fall-related fractures, fall injuries leading to hospital admission, and fall injuries leading to medical attention. We used hierarchical longitudinal linear models to assess HRQOL. For recurrent event models, intervention versus control incidence rate ratios were 0.97 (95% confidence interval [CI], 0.93-1.00; p = 0.048) for falls, 0.93 (95% CI, 0.80-1.08; p = 0.337) for self-reported fractures, 0.89 (95% CI, 0.73-1.07; p = 0.205) for adjudicated fractures, 0.91 (95% CI, 0.77-1.07; p = 0.263) for falls leading to hospital admission, and 0.97 (95% CI, 0.89-1.06; p = 0.477) for falls leading to medical attention. Similar effect sizes (non-significant) were obtained for dichotomous outcomes (e.g., participants with ≥1 events). The difference in least square mean change over time in EQ-5D-5L (intervention minus control) was 0.009 (95% CI, -0.002 to 0.019; p = 0.106) at 12 months and 0.005 (95% CI, -0.006 to 0.015; p = 0.384) at 24 months. Across a standard set of outcomes typically reported in fall prevention studies, we observed modest improvements, one of which was statistically significant. Future work should focus on patient-, practice-, and organization-level operational strategies to increase the real-world effectiveness of interventions, and improving the ability to detect small but potentially meaningful clinical effects. gov identifier: NCT02475850.

Sections du résumé

BACKGROUND
Falls are common in older adults and can lead to severe injuries. The Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) trial cluster-randomized 86 primary care practices across 10 health systems to a multifactorial intervention to prevent fall injuries, delivered by registered nurses trained as falls care managers, or enhanced usual care. STRIDE enrolled 5451 community-dwelling older adults age ≥70 at increased fall injury risk.
METHODS
We assessed fall-related outcomes via telephone interviews of participants (or proxies) every 4 months. At baseline, 12 and 24 months, we assessed health-related quality of life (HRQOL) using the EQ-5D-5L and EQ-VAS. We used Poisson models to assess intervention effects on falls, fall-related fractures, fall injuries leading to hospital admission, and fall injuries leading to medical attention. We used hierarchical longitudinal linear models to assess HRQOL.
RESULTS
For recurrent event models, intervention versus control incidence rate ratios were 0.97 (95% confidence interval [CI], 0.93-1.00; p = 0.048) for falls, 0.93 (95% CI, 0.80-1.08; p = 0.337) for self-reported fractures, 0.89 (95% CI, 0.73-1.07; p = 0.205) for adjudicated fractures, 0.91 (95% CI, 0.77-1.07; p = 0.263) for falls leading to hospital admission, and 0.97 (95% CI, 0.89-1.06; p = 0.477) for falls leading to medical attention. Similar effect sizes (non-significant) were obtained for dichotomous outcomes (e.g., participants with ≥1 events). The difference in least square mean change over time in EQ-5D-5L (intervention minus control) was 0.009 (95% CI, -0.002 to 0.019; p = 0.106) at 12 months and 0.005 (95% CI, -0.006 to 0.015; p = 0.384) at 24 months.
CONCLUSIONS
Across a standard set of outcomes typically reported in fall prevention studies, we observed modest improvements, one of which was statistically significant. Future work should focus on patient-, practice-, and organization-level operational strategies to increase the real-world effectiveness of interventions, and improving the ability to detect small but potentially meaningful clinical effects.
CLINICALTRIALS
gov identifier: NCT02475850.

Identifiants

pubmed: 35932279
doi: 10.1111/jgs.17964
pmc: PMC9669115
mid: NIHMS1822538
doi:

Banques de données

ClinicalTrials.gov
['NCT02475850']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3221-3229

Subventions

Organisme : NIA NIH HHS
ID : P30 AG028747
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024824
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021342
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000142
Pays : United States
Organisme : Patient-Centered Outcomes Research Institute
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024832
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024827
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG048270
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG031679
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000114
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR000113
Pays : United States

Informations de copyright

© 2022 Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Références

N Engl J Med. 2020 Jul 9;383(2):129-140
pubmed: 32640131
Value Health. 2019 Aug;22(8):931-941
pubmed: 31426935
BMJ. 2021 Apr 6;373:n740
pubmed: 33824131
Cochrane Database Syst Rev. 2018 Jul 23;7:CD012221
pubmed: 30035305
Value Health. 2018 Sep;21(9):1090-1097
pubmed: 30224114
Am J Epidemiol. 2011 Oct 15;174(8):984-92
pubmed: 21841157
Inj Epidemiol. 2019 Apr 15;6:14
pubmed: 31245263
Age Ageing. 2007 Nov;36(6):656-62
pubmed: 18056731
N Engl J Med. 2020 Nov 5;383(19):1848-1859
pubmed: 33211928
Respir Care. 2015 Jan;60(1):88-95
pubmed: 25336531
Stat Med. 2021 Feb 28;40(5):1306-1320
pubmed: 33316841
N Engl J Med. 2008 Jul 17;359(3):252-61
pubmed: 18635430
Clin Trials. 2021 Apr;18(2):207-214
pubmed: 33678038
J Am Geriatr Soc. 2020 Jun;68(6):1242-1249
pubmed: 32212395
Cochrane Database Syst Rev. 2019 Jan 31;1:CD012424
pubmed: 30703272
J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1495-1501
pubmed: 30020415
N Engl J Med. 2020 Feb 20;382(8):734-743
pubmed: 32074420
J Am Geriatr Soc. 2017 Dec;65(12):2733-2739
pubmed: 29044479
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Am Geriatr Soc. 2021 Jan;69(1):173-179
pubmed: 33037632
J Am Geriatr Soc. 2021 May;69(5):1334-1342
pubmed: 33580718
J Am Geriatr Soc. 2005 Sep;53(9):1618-22
pubmed: 16137297
Health Technol Assess. 2021 May;25(34):1-114
pubmed: 34075875
J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1053-1061
pubmed: 29045582

Auteurs

David A Ganz (DA)

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Geriatric Research, Education and Clinical Center, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA.

Anita H Yuan (AH)

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Erich J Greene (EJ)

Yale Center for Analytical Sciences, Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.

Nancy K Latham (NK)

Boston Claude D. Pepper Older Americans Independence Center, Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Katy Araujo (K)

Yale Claude D. Pepper Older Americans Independence Center, Yale University, New Haven, Connecticut, USA.

Albert L Siu (AL)

Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Geriatric Research, Education and Clinical Center, James J. Peters VA Healthcare System, Bronx, New York, USA.

Jay Magaziner (J)

University of Maryland School of Medicine, Baltimore, Maryland, USA.

Jerry H Gurwitz (JH)

Meyers Health Care Institute, A Joint Endeavor of Reliant Medical Group, Fallon Health, and UMass Chan Medical School, Worcester, Massachusetts, USA.

Albert W Wu (AW)

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Neil B Alexander (NB)

University of Michigan; Geriatric Research Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Robert B Wallace (RB)

University of Iowa, Iowa City, Iowa, USA.

Susan L Greenspan (SL)

Pittsburgh Claude D. Pepper Older Americans Independence Center, Division of Geriatrics and Gerontology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Jeremy Rich (J)

HealthCare Partners Institute for Applied Research and Education, El Segundo, California, USA.

Elena Volpi (E)

University of Texas Medical Branch Claude D. Pepper Older Americans Independence Center; Sealy Center on Aging, The University of Texas Medical Branch, Galveston, Texas, USA.

Stephen C Waring (SC)

Essentia Institute of Rural Health, Essentia Health, Duluth, Minnesota, USA.

Patricia C Dykes (PC)

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Fred Ko (F)

Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Geriatric Research, Education and Clinical Center, James J. Peters VA Healthcare System, Bronx, New York, USA.

Neil M Resnick (NM)

Pittsburgh Claude D. Pepper Older Americans Independence Center, Division of Geriatrics and Gerontology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Siobhan K McMahon (SK)

School of Nursing, University of Minnesota, Minneapolis, Minnesota, USA.

Shehzad Basaria (S)

Boston Claude D. Pepper Older Americans Independence Center, Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Rixin Wang (R)

Yale Center for Medical Informatics, New Haven, Connecticut, USA.

Charles Lu (C)

Yale Center for Medical Informatics, New Haven, Connecticut, USA.

Denise Esserman (D)

Yale Center for Analytical Sciences, Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.

James Dziura (J)

Yale Center for Analytical Sciences, Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.

Michael E Miller (ME)

Wake Forest University, School of Medicine, Winston-Salem, North Carolina, USA.

Thomas G Travison (TG)

Boston Claude D. Pepper Older Americans Independence Center, Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts, USA.

Peter Peduzzi (P)

Yale Center for Analytical Sciences, Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.

Shalender Bhasin (S)

Boston Claude D. Pepper Older Americans Independence Center, Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

David B Reuben (DB)

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Thomas M Gill (TM)

Yale Claude D. Pepper Older Americans Independence Center, Yale University, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH